SYNENTEC's new automated cell imager offers increased throughput, high quality images

NewsGuard 100/100 Score

SYNENTEC GmbH, the German manufacturer of automated cell imagers, has launched its latest generation of CELLAVISTA® imagers: CELLAVISTA® 4. The new system has a significantly increased throughput, capable of scanning one 96 well microplate at 10X magnification in only 3 to 4 minutes. CELLAVISTA® 4 also has a number of other new features including:

  • enhanced harmonic motion for microplate scanning without agitation,
  • redesigned highly sensitive optics and HCS-grade lenses,
  • 3 times more sensitive fluorescence module, enabling shorter exposures and less photobleaching, and
  • faster autofocus performance.

Stefan Hummel, co-founder and CEO of SYNENTEC, says:

When researchers are looking to save time in their assay work, we need to make sure that our system doesn’t just have a fast throughput, but is also capable of high quality images and state-of-the-art image analysis.”

The new system is available in three models:

  • CLD - with brightfield only,
  • CLD High End - with 6 additional channels of fluorescence, and
  • SCIENTIFIC – which features a 16 bit camera and high numeric aperture objective lenses.

SYNENTEC’s versatile CELLAVISTA® systems, together with their smaller footprint NYONE® series imagers, are used in industry settings for cell line development, bioprocessing, single cell cloning, and preclinical drug development. In academic research settings, they are used in cancer research, immunology, stem cell research, cell biology laboratories, etc.

Source: https://synentec.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New lab assay could make diagnosis and treatment of lung cancer easier